Brandi Robinson | Senior Vice President of Corporate Affairs |
Douglas Williamson | Chief Medical Officer |
Gregory Divis | Chief Executive Officer |
Jennifer Gudeman | Vice President of Medical & Clinical Affairs |
Richard Kim | Chief Commercial Officer |
Tom McHugh | Senior Vice President & Chief Financial Officer |
Francois Brisebois | Oppenheimer |
Marc Goodman | SVB Securities |
Oren Livnat | H.C. Wainwright |
Matt Kaplan | Laddenburg |
Robin Garner | Craig Hallum |
Adam Evertts | LifeSci Capital |
Ladies and gentlemen, thank you for standing by and welcome to the Avadel Pharmaceuticals' First Quarter 2022 Earnings Call. [Operator Instructions] Please be advised that today's conference is being recorded. [Operator Instructions] I would now like to hand the conference over to your speaker, Ms. Brandi Robinson, Senior Vice President of Corporate Affairs. Please go ahead.